Collaborative initiatives and novel AI tools are helping to advance lung cancer screening, but participation barriers and disparities persist despite guideline expansions.
Key Details
- 1Lung cancer screening uptake with low-dose CT (LDCT) increased from 4.5% in 2023 to 16% in 2024, with state variation from 9.7% to 35.5%.
- 2AI deep-learning tools (e.g., from Radboud) have reduced false-positive nodule results by nearly 40%.
- 3Barriers to high screening rates include insurance preauthorization, patient knowledge, provider communication, and logistical factors.
- 4The ACR Lung Cancer Screening Registry (LCSR) is evolving into the Early Lung Cancer Detection Registry (ELCDR) to improve tracking and follow-up of both screening and incidental nodules.
- 5Guideline updates expanded eligibility, but disparities in demographic participation remain and nodule overdiagnosis is a concern.
- 6RSNA 2025 and other conferences will feature major sessions on personalized AI risk tools and screening strategies.
Why It Matters

Source
AuntMinnie
Related News

Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.

New Rubric Enhances Safety of AI-Generated Radiology Summaries
Researchers developed a five-factor rubric to assess the safety and quality of AI-generated, patient-friendly radiology report summaries.

Healthcare Leader Warns AI Will Dominate Diagnostic Radiology
A leading oncologist urges future radiologists to specialize in interventional procedures due to AI advances in image interpretation.